New Key Statistics Module, Z-Score and F-Score
NAS:CRNX Key Ratios
| Market Cap $ M | 3,779.73 |
| Enterprise Value $ M | 2,936.80 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 6.06 |
| Price/Sales | 647.71 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 4.00 |
| EPS (TTM) $ | -3.70 |
| Beneish M-Score | 0.07 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -11.30 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -13.19 |
| EV-to-EBITDA | -13.26 |
| PEG | -- |
| Shares Outstanding M | 78.86 |
| Net Margin (%) | -5,345.85 |
| Operating Margin % | -5,547.17 |
| Pre-tax Margin (%) | -5,345.85 |
| Quick Ratio | 13.07 |
| Current Ratio | 13.07 |
| ROA % (ttm) | -47.96 |
| ROE % (ttm) | -55.36 |
| ROIC % (ttm) | -495.84 |
| Dividend Yield % | -- |
| Altman Z-Score | 22.05 |
CRNX Number of Guru Trades
CRNX Volume of Guru Trades
Gurus Latest Trades with NAS:CRNX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:CRNX is held by these investors
Total 2
Crinetics Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:CRNX
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers